screening for dementia; screening for cognitive impairment; screening for Alzheimer's disease
Jump to navigation
Jump to search
Indications
- no obvious benefits or harms of screening for dememtia in primary care[21]
* also see cognitive assessment
Diagnostic criteria
- clinical diagnosis of dementia requires cognitive impairment that interferes with activities of daily living[25]
- also see diagnostic criteria for dementia
Laboratory
- CSF tau increases 10 years before onset of dementia[26]
- CSF Abeta42 decreases 18 years before onset of dementia[26]
Clinical significance
- cognitive decline begins 6 years prior to onset of dementia[26]
- intact olfaction & intact global cognition together predict a no progression to dementia[23]
- race & apoE4 genotype may influence odor identification screening & global cognitive screening & their association with risk of dementia[23]
Procedure
- simple cognitive assessment tools
- executive function assessment
- mental status examination
- Folstein mini-mental status examination (MMSE)
- modified mini-mental status examination (MMMSE)#[11]
- of no benefit in assessing risk of MCI progressing to dementia[14]
- MiniCog*
- Montreal Cognitive Assessment (MoCA)*[9]
- MoCA-B useful for illiterate or low-education elderly
- precedence over screening for depression[24]
- others
- Folstein mini-mental status examination (MMSE)
- visuospatial function assessment (language-independent)
- visual association test improves predictive value of the MMSE score for development of dementia[19]
- clock drawing test (also falls in this category)
- somewhat more complex cognitive assessment*[5]
- consisting of:
- mini mental status examination
- neuropsychological testing
- episodic/recall ability
- verbal fluency
- visuospatial skills
- detects 18% of early-stage Alzheimer's disease developing within 3 years
- 100% predictive value for development of early Alzheimer's disease
- consisting of:
- screening for depression
- QuoCo tool (cognitive chart)
- cognitive screening by telephone 10-CS[22]
- 10-point cognitive screen
- 1 point each for correct year, month, & date
- 1 point for each of 3 named objects that are remembered several minutes later
- points for naming animals
- 4 points for >= 15 animals for fewer animals
- instructions for administering & scoring the 10-CS are available free of charge in the online supplement of[22]
- 10-point cognitive screen
* free tools validated in primary care populations[10]
# MMSE may be better than MoCA for cognitive screening in African American patients
# MoCA is better than MMSE for detecting MCI in the elderly, particularly in the oldest old population[12][13]
Radiology
- PET scan with Pittsburg compound B for amyloid*
- brain MRI for hippocampal atrophy* & white matter lesions*
- shrinkage of hippocampal volume 8 years before onset of dementia[26]
* presence of 2 of 3 predicts dementia
* hippocampal atrophy associated with 5-fold risk
* white matter lesions associated with ~3-fold risk[8]
Management
- insufficient evidence to recommend for or against screening[1]
- screening best postponed until effective therapy available[4]
- consider screening for all older adults, despite lack of effective treatment[2]
- actually 2-5% of cases are due to reversible causes[3]
- early warnings could avoid problems with
- driving
- financial mismanagement
- social isolation
- screening of nursing home residents for dementia does not reduce emergency department transfers[20]
- a healthy diet, adequate sleep, & exercise should be part of recommendations for every patient, regardless of cognitive complaints[6]
More general terms
Additional terms
References
- ↑ 1.0 1.1 US Preventive Services Task Force Screening for Dementia June 2003 http://www.uspreventiveservicestaskforce.org/3rduspstf/dementia/dementrr.htm
updated Sept, 2014
Owens DK et al. Screening for cognitive impairment in older adults: US Preventive Services Task Force recommendation statement. JAMA 2020 Feb 25; 323:757. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32096858 https://jamanetwork.com/journals/jama/fullarticle/2761651
Patnode CD et al. Screening for cognitive impairment in older adults: Updated evidence report and systematic review for the US Preventive Services Task Force. JAMA 2020 Feb 25; 323:764. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32096857 https://jamanetwork.com/journals/jama/fullarticle/2761650
Petersen RC. Yaffe K. Issues and questions surrounding screening for cognitive impairment in older patients. JAMA 2020 Feb 25; 323:722. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32096831 https://jamanetwork.com/journals/jama/fullarticle/2761621 - ↑ 2.0 2.1 McCarten JR et al Screening for Cognitive Impairment in an Elderly Veteran Population: Acceptability and Results Using Different Versions of the Mini-Cog Journal of the American Geriatrics Society, 59: 309-313 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/21314650 <Internet> http://onlinelibrary.wiley.com/doi/10.1111/j.1532-5415.2010.03249.x/abstract
- ↑ 3.0 3.1 Geriatrics at your Fingertips, 13th edition, 2011 Reuben DB et al (eds) American Geriatric Society
- ↑ 4.0 4.1 Journal Watch 23(6):48, 2003 Palmer K et al Detection of Alzheimer's disease and dementia in the preclinical phase: population based cohort study. BMJ 326:245, 2003 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/12560271 <Internet> http://bmj.com/cgi/content/full/326/7383/245
- ↑ 5.0 5.1 Journal Watch 23(12):93, 2003 Tan ZS, Seshadri S, Beiser A, Wilson PW, Kiel DP, Tocco M, D'Agostino RB, Wolf PA. Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study. Arch Intern Med. 2003 May 12;163(9):1053-7. PMID: https://www.ncbi.nlm.nih.gov/pubmed/12742802
- ↑ 6.0 6.1 Le Couteur DG et al. Political drive to screen for pre-dementia: Not evidence based and ignores the harms of diagnosis. BMJ 2013 Sep 9; 347:f5125 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/24018000 <Internet> http://www.bmj.com/content/347/bmj.f5125
- ↑ Moyer VA; U.S. Preventive Services Task Force Screening for cognitive impairment in older adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014 Jun 3;160(11):791-7 PMID: https://www.ncbi.nlm.nih.gov/pubmed/24663815
- ↑ 8.0 8.1 Lopez OL et al. Amyloid, neurodegeneration, and small vessel disease as predictors of dementia in the oldest-old. Neurology 2014 Nov 11; 83:1804 http://www.neurology.org/content/83/20/1804
- ↑ 9.0 9.1 Geriatric Review Syllabus, 9th edition (GRS9) Medinal-Walpole A, Pacala JT, Porter JF (eds) American Geriatrics Society, 2016
- ↑ 10.0 10.1 Medical Knowledge Self Assessment Program (MKSAP) 17, American College of Physicians, Philadelphia 2015
- ↑ 11.0 11.1 Sink KM, Craft S, Smith SC et al Montreal Cognitive Assessment and Modified Mini Mental State Examination in African Americans. J Aging Res. 2015;2015:872018. Epub 2015 Nov 4. PMID: https://www.ncbi.nlm.nih.gov/pubmed/26618003 Free PMC Article
- ↑ 12.0 12.1 Tan JP, Li N, Gao J et al Optimal cutoff scores for dementia and mild cognitive impairment of the Montreal Cognitive Assessment among elderly and oldest-old Chinese population. J Alzheimers Dis. 2015;43(4):1403-12. PMID: https://www.ncbi.nlm.nih.gov/pubmed/25147113
- ↑ 13.0 13.1 Trzepacz PT, Hochstetler H, Wang S et al Relationship between the Montreal Cognitive Assessment and Mini-mental State Examination for assessment of mild cognitive impairment in older adults. BMC Geriatr. 2015 Sep 7;15:107. PMID: https://www.ncbi.nlm.nih.gov/pubmed/26346644 Free PMC Article
- ↑ 14.0 14.1 Arevalo-Rodriguez I, Smailagic N et al Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev. 2015 Mar 5;(3):CD010783 Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/25740785
- ↑ Dong Y, Lee WY, Basri NA et al The Montreal Cognitive Assessment is superior to the Mini- Mental State Examination in detecting patients at higher risk of dementia. Int Psychogeriatr. 2012 Nov;24(11):1749-55. PMID: https://www.ncbi.nlm.nih.gov/pubmed/22687278
- ↑ Velayudhan L, Ryu SH, Raczek M et al Review of brief cognitive tests for patients with suspected dementia.. Int Psychogeriatr. 2014 Aug;26(8):1247-62. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/24685119 Free PMC Article
- ↑ Tsoi KK, Chan JY, Hirai HW, Wong SY, Kwok TC. Cognitive Tests to Detect Dementia: A Systematic Review and Meta-analysis. JAMA Intern Med. 2015 Sep;175(9):1450-8. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/26052687
- ↑ Newman JC. Copyright and bedside cognitive testing: why we need alternatives to the Mini-Mental State Examination. JAMA Intern Med. 2015;175(9):1459 PMID: https://www.ncbi.nlm.nih.gov/pubmed/26053392
- ↑ 19.0 19.1 Jongstra S, van Gool WA, Moll van Charante EP et al Improving Prediction of Dementia in Primary Care. Ann Fam Med May/June 2018 vol. 16 no. 3 206-210 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/29760023 Free Article <Internet> http://www.annfammed.org/content/16/3/206
- ↑ 20.0 20.1 Rolland Y, Tavassoli N, de Souto Barreto P et al Systematic Dementia Screening by Multidisciplinary Team Meetings in Nursing Homes for Reducing Emergency Department Transfers: The IDEM Cluster Randomized Clinical Trial. JAMA Netw Open. 2020 Feb 5;3(2):e200049. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32101308 Free Article
- ↑ 21.0 21.1 Fowler NR, Perkins AJ, Gao S, Sachs GA, Boustani MA. Risks and Benefits of Screening for Dementia in Primary Care: The Indiana University Cognitive Health Outcomes Investigation of the Comparative Effectiveness of Dementia Screening (IU CHOICE)Trial. J Am Geriatr Soc 2020 Mar; 68:535. PMID: https://www.ncbi.nlm.nih.gov/pubmed/31792940 https://onlinelibrary.wiley.com/doi/abs/10.1111/jgs.16247
- ↑ 22.0 22.1 22.2 Rico BMH et al. Advancing cognitive assessment in telemedicine: Validity and reliability of the telephone 10-point cognitive screener. J Am Geriatr Soc 2023 Mar; 71:977. PMID: https://www.ncbi.nlm.nih.gov/pubmed/36273404 https://agsjournals.onlinelibrary.wiley.com/doi/10.1111/jgs.18091
- ↑ 23.0 23.1 23.2 Motter JN et al. Association of performance on olfactory and cognitive screening tests with conversion to dementia in a biracial cohort of older adults. Neurology 2023 Jul 6; [e-pub] PMID: https://www.ncbi.nlm.nih.gov/pubmed/37414570
- ↑ 24.0 24.1 NEJM Knowledge+
- ↑ 25.0 25.1 Section II, Neurocognitve Disorders. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington DC: American Psychiatric Association; 2013:602
Mao HF, Chang LH, Tsai AY et al Diagnostic accuracy of Instrumental Activities of Daily Living for dementia in community-dwelling older adults. Age Ageing. 2018 Jul 1;47(4):551-557 PMID: https://www.ncbi.nlm.nih.gov/pubmed/29528375 - ↑ 26.0 26.1 26.2 26.3 26.4 Jia J et al. Biomarker changes during 20 years preceding Alzheimer's Disease. N Engl J Med 2024 Feb 21; 390:712-722 PMID: https://www.ncbi.nlm.nih.gov/pubmed/38381674 https://www.nejm.org/doi/10.1056/NEJMoa2310168